# A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers

> **NCT02602860** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 13 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **RADIATION:** [11C]UCB-J
- **DRUG:** Brivaracetam
- **DRUG:** Levetiracetam
- **DRUG:** Brivaracetam

## Key facts

- **NCT ID:** NCT02602860
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602860, "A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02602860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*